CDKN2A p.Glu69Ala
c.206A>C · rs372670098 · VCV2891892
Computational evidence
| Protein change | ||
| AlphaMissense | 0.2904 | likely benign |
|---|---|---|
| REVEL | 0.259 | benign-leaning |
| SaProt | LLR -8.61 | tolerated |
| ⇒ AlphaMissense, REVEL and SaProt all call this tolerated. | ||
| Splicing | ||
| SpliceAI | — | not assessed · no allele here is in the release |
| Constraint at this position | ||
| Conservation | phyloP 7.7 | GERP 2, phastCons 1 |
| Regional constraint | o/e 1.13 | unconstrained · MANE · 6,595 bp · p 0.04 · regional, not allelic |
| Overall | ||
| CADD | 24.3 | PHRED · no single calibrated threshold — expert panels disagree |
ClinVar classifies this uncertain; the computational predictors unanimously lean tolerated — a triage signal, not a reclassification
AlphaMissense carries the ACMG weight for missense; REVEL and SaProt are independent agreement signals.
Population frequency
Absent from gnomAD v4.1. Not observed in any sequenced alleles — a rarity signal (ACMG PM2-supporting), not evidence of pathogenicity on its own.
Variant & gene context
- Gene
- CDKN2A
- Protein
- p.Glu69Ala
- Coding
- c.206A>C
- MANE Select
- NM_000077
- dbSNP
- rs372670098
- Type
- single nucleotide variant
- Location
- chr9:21971153 (GRCh38)
- Gene constraint
- LOEUF 0.791 · pLI 0.62 · ClinGen HI 3/3 (gnomAD)
- Structure
- AlphaFold pLDDT 77.02 · 5 PDB
- Residue 69
- a UniProt-annotated variant site (in melanoma; loss of cdk4 binding); a UniProt-annotated variant site (found in some patients with melanoma; partial loss of cdk4 binding); a UniProt-annotated variant site (in a bladder tumor); a UniProt-annotated variant site (in a lung tumor); the 'disordered' region
Disease context
familial melanoma — disease report on Sugi Atlas → Associated genes, phenotypes, clinical trials & treatmentsFor Familial melanoma (Orphanet):
- Inheritance
- Autosomal dominant, Multigenic/multifactorial
- Onset
- Adult
- Prevalence
- 1-9 / 100 000 (Europe)
Similar variants
- CDKN2A p.Glu69Asp Uncertain significance ★★ ⚠ same residue
- CDKN2A p.Glu69= Conflicting classifications of pathogenicity ★ same residue
- CDKN2A p.Glu69Gly Conflicting classifications of pathogenicity ★ ⚠ same residue
- CDKN2A p.Glu69Lys Uncertain significance ★ ⚠ same residue
- CDKN2A p.Glu69Ter Pathogenic ★ same residue
- CDKN2A c.150+1G>A Likely pathogenic ★★ same condition
- CDKN2A c.151-1G>A Pathogenic ★★ same condition
- CDKN2A c.151-1G>C Pathogenic ★★ same condition
Built on 18 open, versioned datasets — ClinVar, gnomAD, AlphaMissense, REVEL, ClinGen & more — plus Sugi Variant's own cross-source analysis. Source data 2026-01–2026-10, ClinVar 2026-10. Full sources & versions →
Cite Sugi Variant
Gür T. Sugi Variant: A Deterministic Per-Variant Germline Reference from a Knowledge Graph for Humans and AI Agents. 2026. doi:10.5281/zenodo.21509445. This variant: https://sugi.bio/variant/cdkn2a-p-glu69ala (accessed [today's date]).
Preprint & method: sugi.bio/variant/method Machine-readable: this page as Markdown